Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50,369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
Chen Y, Yin T, Xi S, Zhang S, Yan H, Tang Y, Qian J, Chen J, Su X, Du Z, Wang L, Qin Q, Gao C, Zheng Y, Zhao X, Cheng X, Li Z, Zhang W, Chen H, Wang J, Yang Z, Li H, Liu H, Zhou X, Qu B, Xiang D, Guo Y, Wang L, Nie S, Fu G, Yang M, Cai S. Chen Y, et al. Among authors: yang m, yang z. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1194-1204. doi: 10.1002/ccd.28325. Epub 2019 May 21. Catheter Cardiovasc Interv. 2019. PMID: 31112635
Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
Wang G, Wang H, Xu B, Yang Y, Yang Z, Li H, Zhang Z, Wang H, Yang L, Han Y. Wang G, et al. Among authors: yang l, yang y, yang z. Catheter Cardiovasc Interv. 2017 Mar;89(S1):512-519. doi: 10.1002/ccd.26887. Epub 2017 Jan 23. Catheter Cardiovasc Interv. 2017. PMID: 28112473
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
Association Between Platelet Glycoprotein IIb/IIIa Inhibition and In-Hospital Outcomes in ST-Elevation Myocardial Infarction Patients Treated with Coronary Thrombus Aspiration: Findings from the CCC-ACS Project.
Liu W, Li Z, Yang T, A G, Sun H, Liu H, Song X, Jin Z, Li L, Li Y, Hao Y, Liu J, Zhao D, Zhou X, Yang Q; CCC-ACS investigators. Liu W, et al. Among authors: yang t, yang q. Cardiovasc Drugs Ther. 2024 Apr;38(2):315-325. doi: 10.1007/s10557-022-07398-w. Epub 2022 Nov 7. Cardiovasc Drugs Ther. 2024. PMID: 36342561
In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome Project.
Yang N, Liu J, Liu J, Hao Y, Smith JSC, Huo Y, Fonarow GC, Ge J, Morgan L, Ma C, Han Y, Zhao D; Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project investigators. Yang N, et al. Age Ageing. 2022 Nov 1;51(11):afac231. doi: 10.1093/ageing/afac231. Age Ageing. 2022. PMID: 36413586 Clinical Trial.
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC-ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project.
Wang Y, Geng Y, Zhang O, Xu Q, Xue Y, Zhou B, Zhang P; CCC-ACS Investigators. Wang Y, et al. Eur J Med Res. 2023 Feb 2;28(1):59. doi: 10.1186/s40001-023-01025-6. Eur J Med Res. 2023. PMID: 36732830 Free PMC article.
Efficacy and Safety of a Biodegradable Polymer Cobalt-Chromium Sirolimus-Eluting Stent (EXCEL2) in Treating De Novo Coronary Artery Disease: A Pooled Analysis of the CREDIT II and CREDIT III Trials. DOI: 10.1002/ccd.26887.
Wang G, Wang H, Xu B, Yang Y, Yang Z, Li H, Zhang Z, Wang H, Yang L, Han Y. Wang G, et al. Among authors: yang l, yang y, yang z. Catheter Cardiovasc Interv. 2017 Oct 1;90(4):701. doi: 10.1002/ccd.27352. Catheter Cardiovasc Interv. 2017. PMID: 28990343 No abstract available.
50,369 results
You have reached the last available page of results. Please see the User Guide for more information.